AU2690592A - Method to detect tumor necrosis factor (tnf) as bioactive form - Google Patents

Method to detect tumor necrosis factor (tnf) as bioactive form

Info

Publication number
AU2690592A
AU2690592A AU26905/92A AU2690592A AU2690592A AU 2690592 A AU2690592 A AU 2690592A AU 26905/92 A AU26905/92 A AU 26905/92A AU 2690592 A AU2690592 A AU 2690592A AU 2690592 A AU2690592 A AU 2690592A
Authority
AU
Australia
Prior art keywords
tnf
necrosis factor
tumor necrosis
detect tumor
bioactive form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26905/92A
Inventor
Angelo Corti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecnogen SpA
Original Assignee
Tecnogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen SpA filed Critical Tecnogen SpA
Publication of AU2690592A publication Critical patent/AU2690592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU26905/92A 1991-09-23 1992-09-17 Method to detect tumor necrosis factor (tnf) as bioactive form Abandoned AU2690592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM910710A IT1249708B (en) 1991-09-23 1991-09-23 METHOD FOR DETERMINING THE TUMORAL NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM.
ITRM91A0710 1991-09-23

Publications (1)

Publication Number Publication Date
AU2690592A true AU2690592A (en) 1993-04-27

Family

ID=11400369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26905/92A Abandoned AU2690592A (en) 1991-09-23 1992-09-17 Method to detect tumor necrosis factor (tnf) as bioactive form

Country Status (5)

Country Link
EP (1) EP0605635A1 (en)
JP (1) JPH07502113A (en)
AU (1) AU2690592A (en)
IT (1) IT1249708B (en)
WO (1) WO1993006489A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112409B2 (en) 1999-01-29 2006-09-26 Center For Molecular Medicine And Immunology Method of determining cytokine dosage for myelosuppressive state
US6649352B1 (en) * 1999-01-29 2003-11-18 Center For Molecular Medicine And Immunology Method of evaluating myelosuppressive state
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope

Also Published As

Publication number Publication date
EP0605635A1 (en) 1994-07-13
ITRM910710A1 (en) 1993-03-23
IT1249708B (en) 1995-03-09
ITRM910710A0 (en) 1991-09-23
JPH07502113A (en) 1995-03-02
WO1993006489A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
AU3447389A (en) Tumor necrosis factor formulations
AU5901994A (en) Tumor necrosis factor muteins
AU2822892A (en) Oxygen-scavenging composition
AU8292091A (en) Tnf inhibitors
AU3151993A (en) Ground supported lamp
AU2601792A (en) Ski rack
IL97917A0 (en) Pharmaceutical compositions comprising tnf
AU2068292A (en) Radar apparatus
AU5010685A (en) Human tumor necrosis factor
AU678744B2 (en) Apparatus for adding flavour materials to beverages
AU1600392A (en) Substituted carboxylic acid derivatives
AU646596B2 (en) Substituted imidazolyl-propenoic acid derivatives
AU4465889A (en) Recovery of humic acids
GB9401977D0 (en) Tumor necrosis factor muteins
AU1346488A (en) Arginine-depleted human tumor necrosis factor
AU2690592A (en) Method to detect tumor necrosis factor (tnf) as bioactive form
AU1432092A (en) Quinoxaline phosphono-amino acids
ZA919178B (en) Tnf inhibitors
AU6449586A (en) Tumor necrosis factor porification
AU8381091A (en) Mesogenic glycidyl esters
AU3725893A (en) TNF inhibitors
AU2209892A (en) Improvements to heat recovery apparatus
AU2753092A (en) Osteoclast colony stimulating factor (o-csf)
AU6053494A (en) Improvements to footwear
AU1541592A (en) Pressure-processed foods